Haptic-assistive technologies for audition and vision sensory disabilities.

Purpose: The aim of this review is to analyze haptic sensory substitution technologies for deaf, blind and deaf-blind individuals.

Method: The literature search has been performed in Scopus, PubMed and Google Scholar databases using selected keywords, analyzing studies from 1960s to present. Search on databases for scientific publications has been accompanied by web search for commercial devices.

Encapsulation of Piezoelectric Transducers for Sensory Augmentation and Substitution with Wearable Haptic Devices.

The integration of polymeric actuators in haptic displays is widespread nowadays, especially in virtual reality and rehabilitation applications. However, we are still far from optimizing the transducer ability in conveying sensory information. Here, we present a vibrotactile actuator characterized by a piezoelectric disk embedded in a polydimethylsiloxane (PDMS) shell.

Frontiers of robotic endoscopic capsules: a review.

Digestive diseases are a major burden for society and healthcare systems, and with an aging population, the importance of their effective management will become critical. Healthcare systems worldwide already struggle to insure quality and affordability of healthcare delivery and this will be a significant challenge in the midterm future. Wireless capsule endoscopy (WCE), introduced in 2000 by Given Imaging Ltd.

Piezoelectric energy harvesting solutions.

This paper reviews the state of the art in piezoelectric energy harvesting. It presents the basics of piezoelectricity and discusses materials choice. The work places emphasis on material operating modes and device configurations, from resonant to non-resonant devices and also to rotational solutions.

Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.

Objectives: (i) To generate a new heterodinucleotide (3TCpPMPA) comprising the drugs lamivudine and tenofovir which have been shown to act synergistically and (ii) to protect macrophages from 'de novo' HIV-1-infection through its administration.

Methods: 3TCpPMPA was obtained by coupling the morpholidate derivative of tenofovir with the mono n-tri-butylammonium salt of lamivudine 5'-monophosphate. Stability and metabolism were evaluated in vitro and in vivo in mice.